GlaxoSmithKline, GSK is a British pharmaceutical company, one of the largest in the world.

Revenue(RF), mln.USD
326
Assets(RF), mln.USD
154
Capital(RF), mln.USD
104
Glob.Revenue, mln.USD
37707
Staff(RF), 2021
252
Taxes(RF), mln.USD
14

Stopped the advertising company; stopped clinical trials.

The Company Statement
May 24, 2023

Will continue to supply essential medicines, vaccines, medical devices, and equipment in Russia. Halted clinical trials, advertising, and promotion. Russian sales proceeds to go to humanitarian aid (no manufacturing and little raw materia/suply chain reliance). Still operating in Russia with increasing sales and profit volumes in 2022 vs 2021. After the start of Russia's war against Ukraine, the volume of product exports to Russia increased.

September 30, 2024Our response to the situation in Ukraine | GSK
July 02, 2024FAS suspended the purchase of the Russian generic of the anti-HIV drug dolutegravir following a complaint from the British GSK
June 06, 2022GSK stops sales of supplement, vitamin to Russia
March 17, 2022Our response to the situation in Ukraine | GSK
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner